Financhill
Back

Creative Realities Vs. CRISPR Therapeutics AG Industry Stock Comparison

Sell
32

CREX
Creative Realities

Last Price:
$1.77
Seasonality Move:
-1.22%
Sell
36

CRSP
CRISPR Therapeutics AG

Last Price:
$37.24
Seasonality Move:
22.33%
Sell
32
Creative Realities (CREX) is a Sell

Is Creative Realities a Buy, Sell or Hold?

  • The current Creative Realities [CREX] share price is $1.66. The Score for CREX is 32, which is 36% below its historic median score of 50, and infers higher risk than normal.
  • CREX is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
36
CRISPR Therapeutics AG (CRSP) is a Sell

Is CRISPR Therapeutics AG a Buy, Sell or Hold?

  • The current CRISPR Therapeutics AG [CRSP] share price is $37.59. The Score for CRSP is 36, which is 28% below its historic median score of 50, and infers higher risk than normal.
  • CRSP is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

CREX Stock Price Chart

What is Creative Realities's stock price today?

  • The Creative Realities share price today is $1.66
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CREX is experiencing slight selling pressure.

CRSP Stock Price Chart

What is CRISPR Therapeutics AG's stock price today?

  • The CRISPR Therapeutics AG share price today is $37.59
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CRSP is experiencing buying pressure, which is a positive indicator for future bullish movement.

CREX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.11 Buy
Relative Strength Index (14 RSI): 47.11 Sell
Chaikin Money Flow: -9869 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (1.39 - 1.81) Buy
Bollinger Bands (100): (1.71 - 2.65) Sell

CRSP Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 1.85 Buy
Relative Strength Index (14 RSI): 50.97 Buy
Chaikin Money Flow: 1002793 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (34.67 - 39.15) Buy
Bollinger Bands (100): (36.56 - 44.44) Sell

CREX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 1.75 Sell
20-day SMA: 1.62 Buy
50-day SMA: 1.76 Sell
200-day SMA: 3.19 Sell
8-day EMA: 1.71 Sell
20-day EMA: 1.65 Buy
50-day EMA: 1.31 Buy
200-day EMA: 0.53 Buy

CRSP Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 36.3 Buy
20-day SMA: 37.53 Buy
50-day SMA: 38.55 Sell
200-day SMA: 44.73 Sell
8-day EMA: 36.45 Buy
20-day EMA: 35.9 Buy
50-day EMA: 28.51 Buy
200-day EMA: 11.44 Buy

Creative Realities Earnings Growth & CREX Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

CRISPR Therapeutics AG Earnings Growth & CRSP Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.09 per share, an increase next quarter of $0.15 per share, a decrease this year of $0.24 per share, and an increase next year of $1.00 per share.

Creative Realities Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

CRISPR Therapeutics AG Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):